NEW YORK ( TheStreet) -- CHANGE IN RATINGSAmerisourceBergen ( ABC) was downgraded at Leerink Swann to Market Perform. Industry is facing growth headwinds, Leerink Swann said. Abercrombie & Fitch ( ANF) was upgraded at Wedbush from Neutral to Outperform. $45 price target. Earnings visibility is improving and the current valuation is compelling, Wedbush said. Bally Technologies ( BYI) was downgraded at Deutsche Bank from Buy to Hold. $49 price target. Company is operating in a difficult environment, Deutsche said. Costar ( CSGP) was downgraded at Morgan Stanley from Equal-weight to Underweight, Morgan Stanley said. Valuation call, based on a $73 price target, Morgan Stanley said. Convergys ( CVG) was downgraded at Oppenheimer from Outperform to Perform. Valuation call, as the stock has gained 23% year-to-date, Oppenheimer said. Genomic Health ( GHDX) was initiated at Bank of America/Merrill Lynch with a Buy rating. $44 price target. Company has a strong track record for innovation and execution, BofA/Merrill said. GNC ( GNC) was downgraded at Deutsche Bank from Buy to Hold. $42 price target. Valuation call, as the stock is up 30% since early January. Deutsche said. Georgia Gulf ( GGS) was downgraded to Sell at TheStreet Ratings. Kinder Morgan ( KMI) was upgraded at JP Morgan from Neutral to Overweight. $39 price target. Growth visibility is improving, JP Morgan said. Northwestern ( NWE) was upgraded at Keybanc from Hold to Buy. $39 price target. Stock has underperformed its peers, but the company has attractive investment opportunities, Keybanc said. Oi SA ( OIBR) was downgraded to Sell at TheStreet Ratings. Sina Corp. ( SINA) was downgraded at Jefferies to Hold from Buy. $56 price target. Monetization takes time, Jefferies said. Sprint Nextel ( S) was upgraded to Hold at TheStreet Ratings. Staples ( SPLS) was downgraded to Sell from Neutral, Citigroup said. $10 price target. 2Q results sink on ongoing challenges, Citi said. Steel Dynamics ( STLD) was upgraded to Buy at TheStreet Ratings.
STOCK COMMENTS / EPS CHANGES
Agilent Technologies ( A) numbers were lowered at Jefferies. Shares are now seen reaching $55. Estimates were also lowered on fierce cyclical headwinds, Jefferies said. Buy rating. Agilent numbers were lowered at Citigroup. Shares are now seen reaching $46. Estimates also lowered on third-quarter shortfall and more challenging outlook, Citi said. Buy rating. Abercrombie & Fitch numbers were raised at UBS. Shares are now seen reaching $36. Estimates also raised on anticipation of share repurchase, UBS said. Neutral rating. Salesforce.com ( CRM) numbers raised at ThinkEquity. Shares are now seen reaching $165. Estimates were also increased, following channel checks, ThinkEquity said. Buy rating.